M
Medicus Pharma Ltd. (MDCX)
NCM – Real Time Price. Currency in USD
0.46
+0.01 (2.92%)
At close: Jun 26, 2026, 4:00 PM EDT
0.47
+0.01 (2.03%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.46
+0.01 (2.92%)
At close: Jun 26, 2026, 4:00 PM EDT
0.47
+0.01 (2.03%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $4.6M significantly exceed its total debt $1.8M, ensuring strong financial flexibility
Total current assets $5.2M exceed Total current liabilities $4.3M, highlighting excellent liquidity
Debt-to-equity ratio (1.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-22.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$6.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.22 | 1.97 | 7.0 | |
| Quick ratio | 1.22 | 1.37 | 7.0 | |
| Debt to Equity | 1.91 | -7.73 | 3.0 | |
| Debt to Assets | 0.34 | 0.29 | 6.0 | |
| Interest coverage | -22.94 | 36.83 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -752K | -4M | -8M | -18M | -21M |
| Net Income | -1M | -4M | -8M | -25M | -29M |
| EBITDA | -752K | -4M | -8M | -18M | -21M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 67.05 | 1.0 | |
| Operating margin % | N/A | 0.14 | 1.0 | |
| Net margin % | N/A | 9.34 | 1.0 | |
| EBITDA margin % | N/A | 19.90 | 1.0 | |
| Cash flow margin % | N/A | 21.79 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 68.99 | 5.5 |
| Next quarter | N/A | 91.37 | 5.5 |
| Current year | N/A | 81.14 | 5.5 |
| Next year | N/A | 23.87 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -12.29 | 38.61 | -41.66 | 5.5 |
| Y/Y | 999 | -85.36 | 26.19 | -136.99 | 5.5 |
| 3y average | 999 | -173.72 | -50.42 | -180.02 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |